Successful treatment of Keratitis caused by Mycobacterium chelonae and an overview of previous cases in Europe
- PMID: 39385246
- PMCID: PMC11465828
- DOI: 10.1186/s12941-024-00752-w
Successful treatment of Keratitis caused by Mycobacterium chelonae and an overview of previous cases in Europe
Abstract
Introduction and purpose: Mycobacterium (M.) chelonae is responsible for a half of relatively rare nontuberculous mycobacteria (NTM) keratitis. We report a case of M. chelonae keratitis in a woman following sclerocorneal suture extraction after cataract surgery.
Results: A 70-year-old woman presented with a red eye and corneal infiltration of her left eye six weeks following sclerocorneal suture extraction after an elective cataract surgery in another institute. She complained of a sharp, cutting pain and photophobia. Since initial corneal scrapes and conjunctival swabs proved no pathogen using culture and PCR methods, non-specific antibiotics and antifungal agents were administered. As keratitis was complicated by an inflammation in the anterior chamber and vitreous, samples of the vitreous fluid were sent for microbiologic examination. DNA of Epstein-Barr virus (EBV) was repeatedly detected. Since the intrastromal abscess had formed, corneal re-scrapings were performed and M. chelonae was detected using culture, MALDI-TOF MS and PCR methods. Therapy was changed to a combination of oral and topical clarithromycin, intravitreal, topical and intracameral amikacin, and oral and topical moxifloxacin. The successful therapy led to stabilization. The optical penetrating keratoplasty was performed and no signs of the infection recurrence were found.
Conclusions: The diagnosis of nontuberculous mycobacterial keratitis is difficult and often delayed. An aggressive and prolonged antimicrobial therapy should include systemic and topical antibiotics. Surgical intervention in the form of corneal transplantation may be required in the active and nonresponsive infection. In the presented case this was necessary for visual rehabilitation due to scarring.
Keywords: Antibiotic therapy, keratoplasty; Keratitis; Mycobacterium chelonae.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.Cornea. 2015 Aug;34(8):967-71. doi: 10.1097/ICO.0000000000000492. Cornea. 2015. PMID: 26075451
-
Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.Arch Ophthalmol. 2004 Aug;122(8):1166-9. doi: 10.1001/archopht.122.8.1166. Arch Ophthalmol. 2004. PMID: 15302657
-
Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.Clin Ther. 2004 Feb;26(2):191-6. doi: 10.1016/s0149-2918(04)90018-5. Clin Ther. 2004. PMID: 15038942 Review.
-
Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone.Ophthalmology. 2006 Jun;113(6):950-4. doi: 10.1016/j.ophtha.2006.02.028. Epub 2006 Apr 27. Ophthalmology. 2006. PMID: 16647126
-
Bilateral infectious keratitis after laser in situ keratomileusis: a case report and review of the literature.Ophthalmology. 2001 Jan;108(1):121-5. doi: 10.1016/s0161-6420(00)00435-8. Ophthalmology. 2001. PMID: 11150275 Review.
References
-
- Akram SM, Rathish B, Saleh D. Mycobacterium chelonae Infection. [Updated 2023 Feb 25]. 2023 2023 Jan-. In: StatPearls [Internet] [Internet]. Treasure Island, FL StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430806/
-
- Uslu U, Bohm O, Heppt F, Sticherling M. Skin and soft tissue infections caused by Mycobacterium chelonae: more common than expected? Acta Derm Venereol. 2019;99(10):889–93. - PubMed
-
- Lee EY, Ip JW, Fung BK, Ted UE. Mycobacterium chelonae hand infection: a review. Hand Surg. 2009;14(1):7–13. - PubMed
-
- Girgis DO, Karp CL, Miller D. Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management. Clin Exp Ophthalmol. 2012;40(5):467–75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- MH-CZ DRO (UHHK, 00179906)/Ministerstvo Zdravotnictví Ceské Republiky
- MH-CZ DRO (UHHK, 00179906)/Ministerstvo Zdravotnictví Ceské Republiky
- MH-CZ DRO (UHHK, 00179906)/Ministerstvo Zdravotnictví Ceské Republiky
- MH-CZ DRO (UHHK, 00179906)/Ministerstvo Zdravotnictví Ceské Republiky
- NU20-09-00114/Agentura Pro Zdravotnický Výzkum České Republiky
LinkOut - more resources
Full Text Sources
Medical
Research Materials